News Archive

News archive

January 2022
BioBridge and VaxiAm Group announce initiative to help EU animal health companies take advantage of the new possibilities for EU-China trade & China-to-Europe investment. 

October 2021

Meredith Lloyd-Evans is delighted to have been awarded an Honorary Fellowship of TOPRA- The Organisation for Professionals in Regulatory Affairs
in recognition of a significant contribution made to the professional support of TOPRA.

March 2021

Co-authored by Meredith Lloyd-Evans
The contribution of Veterinary Public Health to the management of Covid-19 pandemic from a One Health perspective
can be read at

January 2021

Meredith Lloyd-Evans has authored a section in the latest EUMOFA Blue Bioeconomy Report, on Integrated Multi-Trophic Aquaculture (IMTA).
The full report can be read or downloaded at

November 2020
BioBridge has been asked by HealthforAnimals, the international association for the animal health industry, to assist with a follow-up study to its Global Benchmarking Survey 2020, looking at defence and development costs in more detail.

May 2019
Meredith contributed to “Blue Bioeconomy: Investments & Innovations”, for EUMOFA, the European Market Observatory for Fisheries and Aquaculture Products at the European Maritime Day in Lisbon

April 2019
BioBridge celebrates 30 years of innovation consultancy

Meredith Lloyd-Evans contributed to a session on the Blue Economy sponsored by EC DG MARE at the European Association of Fisheries Economists 2019 conference

November 2017
BioBridge has supported British Antarctic Survey’s DATA AS ART project by buying one of the photographic artworks, Volcanic Ash. It shows a section of ice core from James Ross Island, Antarctica, from a depth of almost 280m, over  900 feet. The vertical dark stripe, visible in the centre, is a layer of volcanic ash embedded in the ice. DATA AS ART celebrates BAS science at the poles, NERC-funded research and highlight NERC’s 50th anniversary year. 

50 Movers and Shakers in BioBusiness 2017 has been published by Miranda Weston-Smith. Meredith Lloyd-Evans was photographed contributing to BioBeat16. Photos by Nigel Luckhurst. Courtesy of Cambridge Judge Business School.
September 2017
Meredith Lloyd-Evans presents at 2nd EMBRIC GA
The 2nd General Assembly of the European Marine Biological Research Infrastructure Cluster  was held in Faro, Portugal.
Meredith was invited to join the GA and present on the outputs and follow-on projects of the EC-funded PharmaSea project
August 2017
Meredith Lloyd-Evans has given a seminar to young biotechnology, bioengineering and extremophile researchers from Chile on the Pathway for Innovation
Please contact us if you have an interest in a similar seminar for your young researchers 

March 2017
The PharmaSea project, of which BioBridge was a partner, has concluded 

BioBridge managed for HealthforAnimals its 5th Global Benchmarking Survey, GBS 2015. The summary of the report is available at

Jan 2015
BioBridge selected for a second time by HealthforAnimals to manage its 5th Global Benchmarking Survey, GBS 2015
Meredith Lloyd-Evans judges the TOPRA Awards for Regulatory Excellence

BioBridge’s 25th Anniversary year 2014

Nov 2014
Meredith Lloyd-Evans represented the PharmaSea project at Natural Product Biotechnology 2014 in Inverness

Oct 2014
Meredith represented and presented PharmaSea at a well-attended EFIB.  PharmaSea held a full day conference ‘Building Blue Biotech Capacity in Europe’ at EFIB 2014. 

Sep 2014
The PharmaSea project’s 2nd General Assembly at the Stazione Zoologica ‘Anton Dohrn’ in Naples, Italy, 7– 9 Sept 2014. Part of the meeting is open to potential end users and other parties with an interest in the discovery of new chemical entities from marine microorganisms with potential pharmaceutical, cosmeceutical or nutraceutical applications. For more information please visit

Apr 2014
BioBridge celebrates 25 years

Jan 2014
ERA-MarineBiotech kick off meeting was held in Lillehammer Norway. This followed the preparatory action CSA MarineBiotech project which was managed by BioBridge.